SAS is teaming up with Constella Group, etrials and Datatrak to form what it calls a “Life Sciences Network” that is designed to provide information management for life science firms.

Constella Group,a provider of health information services, is based in Durham and has operations in seven other US cities as well as the United Kingdom and India.

etrials, which is focused on electronic data capture in clinical trials, is based in RTP.

Datatrak focuses on clinical trials. Its headquarters are in Cleveland.

The goal behind the collaborative effort is to provide pharmaceutical, biotech and medical device firms with what SAS calls a “single data management, analysis and reporting hub.” The announcement was made at the annual Drug Information Association meeting in Washington, DC.

Other companies will be added to the network solution, SAS said.

The network will employ SAS drug development software which is based on the latest SAS 9 Intelligence Platform software that is designed to share data and applications across organizations.

“The Life Sciences Network enables life sciences firms to drastically reduce the risk, time and expense in adopting new technologies for the variety of processes they use on their data,” said Kecia Serwin, general manager of SAS Health and Life Sciences, in a statement. “With the Life Sciences Network, firms can use the premier software and services on the market today to create a cost-effective, integrated system with a single hub for delivering top-of-the-line capabilities.”

Network offerings will include such tools as electronic data capture, electronic patient diaries, interactive voice response systems.

Electronic data capture and other contract research organization services will be provided initially by Constella Group, etrials and Datatrak.

Participation in the network is the latest in a series of partnerships and deals announced by etrials. It recently disclosed a licensing deal with Quintiles Transnational and a consulting partnership with Campbell Alliance.

Constella Group closed on $61 million in new capital in January and also acquired Futures Group, an international provider of health and social programs.


Constella Group: